About Algisys
Algisys is a Healthcare company based in Cleveland (United States) founded in 2009. It operates as an algal-based EPA omega-3 oils and vegan protein are produced. It operates in the Healthcare, Consumer, and Agriculture sectors. Algisys has raised $8.85 million across 5 funding rounds from investors including National Science Foundation. Algisys offers products and services including Algal EPA Omega-3 Oils and High Protein Vegan Biomass. Its focus areas include Life Sciences, Nutraceuticals Tech, Functional Foods and Beverages and Food Additives. Its legal entity is ALGISYS, LLC. Its competitors include Benson Hill, Plantible Foods, Zivo Bioscience, Nutriati and iwi and 4 more; 9 of its 9 listed competitors have raised funding.
Company details
Founded in 2009 and based in Cleveland, United States, operations focus on algal biotechnology for nutrition. A proprietary fermentation process is employed to generate EPA omega-3 oils and vegan protein, utilizing scalable industrial equipment. These products target sectors such as supplements, human and animal nutrition, pharmaceuticals, food and beverage, and cosmetics, providing an alternative to traditional fish-derived sources.
- Headquarters Cleveland, United States
- SectorsHealthcareConsumer Agriculture
- Website algisys.com
- Social LinkedIn
- Legal Name Algisys, Llc
- Total Equity Funding$8.85M (USD)
in 5 rounds
- Latest Funding Round$6.15M (USD), Series A
Aug 2013
- Investors
Products & Services of Algisys
Algisys offers a comprehensive portfolio of products and services, including Algal EPA Omega-3 Oils and High Protein Vegan Biomass.
Sustainable omega-3 fatty acids from microalgae for health benefits.
Vegan protein source derived from proprietary microalgae strains.
Funding Insights of Algisys
Algisys has successfully raised a total of $8.85M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $6.15 million completed in August 2013. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.85M
- Total Rounds 5
- Last Round Series A — $6.15M
- First Round $150,000
(Mar 2010)
- Investors Count 1
All 5 funding rounds of Algisys with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2013 | $6.15M | Series A | – | – | – |
| Jan 2012 | $2.5M | Series A | – | – | – |
| Apr 2011 | $200,000 | Angel Round | – | – | – |
| Jul 2010 | $150,000 | Grant | – | – | |
| Mar 2010 | $150,000 | Grant | – | – |
1 investors in total: 1 institutional.
Investors in Algisys
Algisys has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include National Science Foundation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
A government-backed foundation providing seed-stage investments to support small businesses. | 1950 | nsf.gov | Arlington, United States |
Investor details for Algisys
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Algisys
11 people are tracked at Algisys (5 in leadership, 6 in board & advisors).
| Name | Role | Group |
|---|---|---|
George Antoon | President & COO | Leadership |
Roger Frank | Executive Vice President | Leadership |
Charles Roe | Co-founder, Chief Technology Officer & Board Member | Leadership |
Peter Colella | Chief Executive Officer | Leadership |
Wayne Lorgus | Chief Financial Officer | Leadership |
Michael Finn | Independent Board Member | Board & advisors |
L. Jack Staley | President & Board Chairman | Board & advisors |
Charles Bowman | Independent Board Member | Board & advisors |
Paula Simpson | Advisor | Board & advisors |
Leigh Ann Sayen | Advisor | Board & advisors |
Patricia Barclay | Director And Chair Medical Advisory Board | Board & advisors |
Complete people profiles for Algisys
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Algisys
3 dated milestones of Algisys across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Algisys is founded.
- Funding First funding round of $150K.
- Funding Latest funding round, Series A, of $6.2M.
Competitors of Algisys
Algisys has 9 listed competitors in our database, 9 of them funded. They include Benson Hill, Plantible Foods, Zivo Bioscience, Nutriati and iwi, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bensonhill.com | 2012 | St. Louis, United States | $406.99M | 151 | Provider of plant-based food ingredients | |
| plantiblefoods.com | 2016 | San Marcos, United States | $56.6M | 25 | Producer and supplier of plant-based protein ingredients | |
| zivobioscience.com | 1983 | Keego Harbor, United States | $962,000 | 10 | Bioactive compounds from algal strain | |
| nutriati.com | 2013 | Richmond, United States | $36.89M | – | Processing chickpea to derive alternative protein ingredients for the food industry | |
| iwilife.com | 2017 | Houston, United States | $10M | – | Manufacturer of algae-based nutritional products | |
| terravia.com | 2003 | San Francisco, United States | $60M | – | Algae-based specialty ingredients are manufactured and supplied for food applications. | |
| algenol.com | 2006 | Fort Myers, United States | $65M | 21 | Ethanol is produced directly from algae biomass using patented technology. | |
| proterabio.com | 2018 | Sunnyvale, United States | $15.85M | – | Protein-based enzyme technologies are developed using deep learning algorithms. | |
| aurorainc.com | 2006 | Hayward, United States | $62M | – | Provides technology for algae-based products. |
Detailed competitors of Algisys
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Nutraceutical & Food-as-Medicine Platforms
10 companies that operate in the same segment as Algisys (Nutraceutical & Food-as-Medicine Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Ayurvedic healthcare and nutritional products are provided by Kapiva. | 2016 | Bengaluru, Karnataka, India | USD 77.85 M | USD 27.35 M | 362 | |
Plant-based frozen meals are delivered via weekly subscriptions. | 2016 | London, England, United Kingdom | USD 69.9 M | USD 12.54 M | 146 | |
Therapies for metabolic health in chronic disease patients are provided. | 2014 | San Francisco, California, United States | USD 401.78 M | – | 910 | |
Nutritional supplements for multiple health ailments are developed. | 2005 | Mumbai, Maharashtra, India | USD 1.55 M | – | – | |
Personalized gut health solutions are provided by ZOE. | 2017 | New Castle, Pennsylvania, United States | USD 15 M | – | – | |
Machine learning-based bioinformatics solutions for health insights are provided. | 2016 | Los Alamos, New Mexico, United States | USD 301.57 M | – | – | |
Cellular health supplements for metabolic repair are developed and manufactured. | 2014 | New York, New York, United States | USD 66.1 M | – | – | |
Nutritional food and health supplements are provided by OZiva. | 2010 | Mumbai, Maharashtra, India | USD 17.32 M | USD 23.98 M | – | |
Low-carb products for weight loss are provided by Atkins. | 1960 | Denver, Colorado, United States | USD 15 M | – | – | |
Synbiotic supplements and fermented products for gut health are provided. | 2021 | Mumbai, Maharashtra, India | USD 20.02 M | USD 5.14 M | 88 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Algisys
Algisys was founded in 2009 and raised its 1st funding round 1 year after it was founded.
Algisys is headquartered in Cleveland, United States. It is registered at Cleveland, Ohio, United States.
Algisys is a funded company, having raised a total of $8.85M across 5 funding rounds to date. The company's 1st funding round was a Grant of $150K, raised on Mar 2010.
Founded in 2009 and based in Cleveland, United States, operations focus on algal biotechnology for nutrition. A proprietary fermentation process is employed to generate EPA omega-3 oils and vegan protein, utilizing scalable industrial equipment. These products target sectors such as supplements, human and animal nutrition, pharmaceuticals, food and beverage, and cosmetics, providing an alternative to traditional fish-derived sources.
Algisys's top competitors include Benson Hill, Plantible Foods and Zivo Bioscience.
Algisys offers Algal EPA Omega-3 Oils and High Protein Vegan Biomass.
Algisys has 1 investor. Key investors include National Science Foundation.
Algisys operates through Algisys, Llc.